Mozambican researcher Amade Sambo has developed a vaccine candidate with promising results in fighting pancreatic cancer.
Pancreatic cancer is a disease that arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply uncontrollably and form a tumor. These cancer cells can invade other parts of the body.
After two years of research in Japan, Sambo presented preclinical results demonstrating the efficacy of the chemically synthesized vaccine as a robust platform for the development of immunotherapies against this disease.
With this achievement, Sambo joins a select group of young African scientists who are beginning to excel at internationally renowned research centers, demonstrating the continent's potential for producing scientific knowledge with global impact.
With this research, Amade Sambo shared on social media that he recently completed his master's degree in Chemistry at Osaka University, one of the top 100 higher education institutions in the world. Distinguished for his academic performance, he completed the course with a final grade point average of 19, equivalent to a 96 percent grade point average.
(By MozaVibe)
